Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Masitinib mesilate

EU orphan designation number: EU/3/09/684   
Active ingredient: Masitinib mesilate
Indication: Treatment of pancreatic cancer
Sponsor: AB Science S.A.
3 avenue George V, F-75008 Paris, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/10/2009 Centralised Orphan - Designation EMEA/OD/063/09 (2009)8522 of 28/10/2009